Annual D&A
$322.54 M
+$123.99 M+62.45%
December 31, 2024
Summary
- As of March 14, 2025, BNTX annual depreciation & amortization is $322.54 million, with the most recent change of +$123.99 million (+62.45%) on December 31, 2024.
- During the last 3 years, BNTX annual D&A has risen by +$233.56 million (+262.51%).
- BNTX annual D&A is now at all-time high.
Performance
BNTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$176.71 M
+$125.84 M+247.40%
December 31, 2024
Summary
- As of March 14, 2025, BNTX quarterly depreciation & amortization is $176.71 million, with the most recent change of +$125.84 million (+247.40%) on December 31, 2024.
- Over the past year, BNTX quarterly D&A has increased by +$125.84 million (+247.40%).
- BNTX quarterly D&A is now at all-time high.
Performance
BNTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$322.54 M
+$92.04 M+39.93%
December 31, 2024
Summary
- As of March 14, 2025, BNTX TTM depreciation & amortization is $322.54 million, with the most recent change of +$92.04 million (+39.93%) on December 31, 2024.
- Over the past year, BNTX TTM D&A has increased by +$92.04 million (+39.93%).
- BNTX TTM D&A is now at all-time high.
Performance
BNTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
BNTX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.5% | +247.4% | +39.9% |
| 3 y3 years | +262.5% | +247.4% | +39.9% |
| 5 y5 years | +749.9% | +1439.9% | +671.5% |
BNTX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +262.5% | at high | +484.5% | at high | +262.5% |
| 5 y | 5-year | at high | +749.9% | at high | +1761.9% | at high | +749.9% |
| alltime | all time | at high | +2604.9% | at high | +2065.1% | at high | +3851.9% |
BioNTech SE Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $322.54 M(+62.4%) | $176.71 M(+247.4%) | $322.54 M(+39.9%) |
| Sep 2024 | - | $50.87 M(-4.7%) | $230.50 M(+2.7%) |
| Jun 2024 | - | $53.37 M(+28.3%) | $224.50 M(+8.8%) |
| Mar 2024 | - | $41.60 M(-50.9%) | $206.43 M(+4.0%) |
| Dec 2023 | $198.55 M(+52.7%) | $84.66 M(+88.7%) | $198.55 M(+33.3%) |
| Sep 2023 | - | $44.86 M(+27.1%) | $148.92 M(+10.9%) |
| Jun 2023 | - | $35.30 M(+4.7%) | $134.29 M(+1.1%) |
| Mar 2023 | - | $33.72 M(-3.7%) | $132.79 M(+2.1%) |
| Dec 2022 | $130.03 M(+46.1%) | $35.04 M(+15.9%) | $130.03 M(+3.2%) |
| Sep 2022 | - | $30.23 M(-10.5%) | $125.96 M(+6.5%) |
| Jun 2022 | - | $33.79 M(+9.1%) | $118.31 M(+13.4%) |
| Mar 2022 | - | $30.97 M(+0.0%) | $104.28 M(+17.2%) |
| Dec 2021 | $88.98 M | $30.97 M(+37.2%) | $88.98 M(+24.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $22.58 M(+14.2%) | $71.57 M(+18.4%) |
| Jun 2021 | - | $19.77 M(+26.2%) | $60.47 M(+20.0%) |
| Mar 2021 | - | $15.67 M(+15.5%) | $50.37 M(+14.0%) |
| Dec 2020 | $44.20 M(+16.5%) | $13.56 M(+18.2%) | $44.20 M(+5.7%) |
| Sep 2020 | - | $11.48 M(+18.6%) | $41.81 M(+5.6%) |
| Jun 2020 | - | $9.67 M(+1.9%) | $39.59 M(+0.8%) |
| Mar 2020 | - | $9.49 M(-15.0%) | $39.28 M(+3.5%) |
| Dec 2019 | $37.95 M(+46.2%) | $11.17 M(+20.6%) | $37.95 M(+41.7%) |
| Sep 2019 | - | $9.26 M(-1.0%) | $26.78 M(+52.9%) |
| Jun 2019 | - | $9.36 M(+14.7%) | $17.52 M(+114.7%) |
| Mar 2019 | - | $8.16 M | $8.16 M |
| Dec 2018 | $25.96 M(+117.7%) | - | - |
| Dec 2017 | $11.92 M | - | - |
FAQ
- What is BioNTech SE annual depreciation & amortization?
- What is the all time high annual D&A for BioNTech SE?
- What is BioNTech SE annual D&A year-on-year change?
- What is BioNTech SE quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BioNTech SE?
- What is BioNTech SE quarterly D&A year-on-year change?
- What is BioNTech SE TTM depreciation & amortization?
- What is the all time high TTM D&A for BioNTech SE?
- What is BioNTech SE TTM D&A year-on-year change?
What is BioNTech SE annual depreciation & amortization?
The current annual D&A of BNTX is $322.54 M
What is the all time high annual D&A for BioNTech SE?
BioNTech SE all-time high annual depreciation & amortization is $322.54 M
What is BioNTech SE annual D&A year-on-year change?
Over the past year, BNTX annual depreciation & amortization has changed by +$123.99 M (+62.45%)
What is BioNTech SE quarterly depreciation & amortization?
The current quarterly D&A of BNTX is $176.71 M
What is the all time high quarterly D&A for BioNTech SE?
BioNTech SE all-time high quarterly depreciation & amortization is $176.71 M
What is BioNTech SE quarterly D&A year-on-year change?
Over the past year, BNTX quarterly depreciation & amortization has changed by +$125.84 M (+247.40%)
What is BioNTech SE TTM depreciation & amortization?
The current TTM D&A of BNTX is $322.54 M
What is the all time high TTM D&A for BioNTech SE?
BioNTech SE all-time high TTM depreciation & amortization is $322.54 M
What is BioNTech SE TTM D&A year-on-year change?
Over the past year, BNTX TTM depreciation & amortization has changed by +$92.04 M (+39.93%)